Summary
Eighty patients with osteoarthritis were randomly assigned to either piroxicam (20 mg daily) or diclofenac (75–150 mg daily) in a 12-week double-blind, parallel groups study. In the 70 patients who completed the study, both medications were effective; statistically significant improvement was observed on all assessments of efficacy. However, no statistically significant differences between the two drugs were seen on any of the efficacy parameters measured. There was a trend towards better tolerance in the piroxicam treated patients, although this was not statistically significant; 3 of the 40 piroxicam treated patients versus 6 of the 40 patients on diclofenac were discontinued from the trial due to intolerable adverse events.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abruzzo, J.L., Gordon, G.V., Meyers, A.R. Double-blind study comparing piroxicam and aspirin in the treatment of osteoarthritis. Am J Med 1982, 72, (2A), 45–49.
Ward, J.R. Efficacy of diclofenac in osteoarthritis, experience in the United States. Am J Med 1986, 80, 53–57.
Berry, H., Bloom, B., Hamilton, E.B.D. A comparative study of piroxicam (Feldene), diclofenac and placebo in osteoarthritis. Clin Trials J 1982, 19, 349–358.
Marcolongo, R., Giordano, N., Bassi, G.P., Giannini, R., Borghi, C. et al. Double blind preference and compliance study in Clin Rheumatol 1985, 4, 267–277.
Mehrez, H. Double blind comparison of diclofenac sodium vs piroxicam in the treatment of spondylarthritis. J Med Assoc Thailand, 1985, 67, 3.
Fries, J.F. Measuring the quality of life in relation to arthritis therapy. Postgrad Med. (Special Issue), 1983, 49–53.
Osterman, K. Piroxicam versus slow-release diclofenac in osteoarthritis. Royal Soc Med. Internal Congress and Symposium Series, 1984, 67, 13–17.
Fries, J.F., Spitz, P.W., Young, D.Y. The dimensions of health outcomes: The Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982, 9, 789–793.
Tugwell, P., Bombardier, C., Buchanan, W.W., Goldsmith, C.H., Grace, E., Hanna, B. The MACTAR Patient Preference Disability Questionnaire — an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987, 14, 446–451.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gerecz-Simon, E., Soper, W.Y., Kean, W.F. et al. A controlled comparison of piroxicam and diclofenac in patients with osteoarthritis. Clin Rheumatol 9, 229–234 (1990). https://doi.org/10.1007/BF02031974
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02031974